Clondalkin Group has acquired the Printed Components business of Catalent Pharma Solutions. Terms of the transaction were not disclosed, and closing is subject to receipt of regulatory approval. The unit generated approximately $100 million in annual sales of secondary packaging products out of its four facilities in the U.S., Puerto Rico and Ireland. Clondalkin and Catalent will enter into a long-term supply agreement which ensures that Catalent will continue to be able to provide services t...